CliniGA CRO

CliniGA CRO Blog

Discussing Participant Travel Plans Within Study Scheduling

Holidays, family visits and temporary work travel can overlap with research tasks.

Representative research photograph: Discussing Participant Travel Plans Within Study Scheduling
Photo: U.S. Air Force photo by Senior Airman Melany Bermudez · License: Public domain · Cropped and resized.
Published
Updated

Holidays, family visits and temporary work travel can overlap with research tasks. Making it comfortable to mention plans early reduces uncertainty. Rather than expecting participants to abandon every personal arrangement, staff can assess the specific activities and conditions that would be affected.

Define the workflow

A coordinator can explain planned visits and permitted windows within the appropriate framework. Refer questions about study product, devices, samples or clinical preparation to authorized staff. Do not improvise transport or treatment instructions, or automatically promise an off-protocol visit option.

Worked example

For example, someone will spend two follow-up weeks in another city. The site reviews the affected visit and conditions for home tasks with the investigator. They explain feasible options and unresolved questions; an available calendar slot does not establish that an alternative date meets study conditions.

Practical checks

  • Discuss travel details only to the extent needed for the relevant study activity.
  • Separate scheduling flexibility from authorized decisions about special materials or clinical conditions.
  • Transfer the agreed plan and outstanding questions to relevant teams in appropriate records.

Decision and boundaries

A good discussion explains what the participant should report and who will answer. Sharing a plan is not a basis for continuous tracking or collection of private-life details. Medical and regulatory suitability remain with authorized staff; a coordinator should not independently guarantee safety. Explain how communication will be updated if the plan changes.

Frequently asked questions

Does travel automatically end participation?
Assess the activities affected and study conditions through authorized review rather than applying one universal outcome.
Who gives instructions about travelling with study materials?
Use the relevant authorized staff and approved arrangements. A coordinator should not independently invent transport or clinical rules.

Sources

  1. EMA — ICH E6 Good Clinical Practice
  2. FDA — Conducting clinical trials with decentralized elements